ACLARION, INC. Total Contract Liability
ACLARION, INC. (ACON) had Total Contract Liability of $0 as of 2024-12-31, per its 10-K filed 2025-04-09.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2025-04-09
- 2024-12-31: Contract with Customer, Liability $0.00.
- 2023-12-31: Contract with Customer, Liability $3.63K.
| Period end | Contract with Customer, Liability |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-04-09 |
| 2023-12-31 | $3.63K 10-K · filed 2025-04-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |